Skip to content

Accelerated iTBS for the Upper Limb Function of Subacute Stroke Patients: A Single-Blind, Multicenter, Randomized Controlled Clinical Study

Accelerated iTBS for the Subacute Stroke Patients: A Single-Blind, Multicenter, Randomized Controlled Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110766
Enrollment
Unknown
Registered
2025-10-20
Start date
2025-10-31
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Accelerated iTBS group:accelerated iTBS
LF-rTMS group:LF-rTMS

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients clinically diagnosed with first-ever unilateral hemispheric stroke, with MRI or CT confirming hemorrhagic or ischemic stroke, lesion located in one cerebral hemisphere; 2.Age >=18 to =2 weeks and <=6 months; 4.FMA upper limb score < 50; 5.Informed consent obtained from the patient or their guardian.

Exclusion criteria

Exclusion criteria: 1.Brainstem or cerebellar lesions; 2.Severe systemic diseases, cardiac, hepatic, renal diseases, or infectious diseases; 3.History of epilepsy, psychiatric disorders, or other severe emotional dysfunction disorders; 4.Severe cognitive impairment unable to cooperate with assessment and treatment; 5.Intracranial tumors, skull defects, or implants contraindicated for TMS (e.g., cochlear implants, ventriculoperitoneal shunts, etc.); 6.Used drugs that alter cortical excitability within one month.(For example, antiepileptic drugs such as levetiracetam, sodium valproate, carbamazepine, oxcarbazepine, etc., and anti-anxiety/depression drugs such as sertraline hydrochloride tablets, escitalopram oxalate tablets, agomelatine tablets, and duloxetine hydrochloride enteric-coated capsules, etc.); 7.Modified Ashworth Scale score for upper limbs> 3; 8.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
The Upper Extremity Section of the Fugl-Meyer Assessment, FMA-UE;

Secondary

MeasureTime frame
Wolf motor function test, WMFT;Pinch Strength;Modified Bathel Index,MBI;Rest motor threshold, RMT;Motor evoked potential,MEP;Grip Strength;National Institute of Health Stroke Scale,NIHSS;

Countries

China

Contacts

Public ContactJingming Hou

The First Affiliated Hospital of Army Medical University

jingminghou@hotmail.com+86 23 68766388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 26, 2026